Viridian Therapeutics, Inc.

VRDN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4/A Mar 4, 2026 4/A
4 Mar 4, 2026 4
4 Mar 4, 2026 4
4 Mar 4, 2026 4
144 Mar 4, 2026
144 Mar 4, 2026
144 Mar 4, 2026
144 Mar 4, 2026
S-8 Feb 26, 2026 S-8
10-K Feb 26, 2026 10-K
8-K Feb 26, 2026 8-K
SCHEDULE 13G/A Feb 17, 2026
SCHEDULE 13G/A Feb 13, 2026
4 Jan 2, 2026 4
144 Dec 31, 2025
SCHEDULE 13G/A Nov 14, 2025
10-Q Nov 5, 2025 10-Q
8-K Nov 5, 2025 8-K
SCHEDULE 13D/A Oct 27, 2025
4 Oct 27, 2025 OWNERSHIP DOCUMENT
8-K Oct 23, 2025 8-K
424B5 Oct 23, 2025 424B5
424B5 Oct 21, 2025 424B5
8-K Oct 21, 2025 8-K
8-K Oct 20, 2025 8-K
← Newer Page 3 of 33 · 815 filings Older →